A drug that can be given at the time of a kidney transplant operation will not only cut down the risk of rejection by half but also sets up the foundation for a less toxic regimen of anti-rejection drugs to be used, a new study conducted by Oxford University researchers reveals. The key results are reported in iThe Lancet/i and presented at the World Transplant Congress in San Francisco today. They will help doctors faced with a difficult transplant conundrum: ...
Read More
No comments:
Post a Comment